USF ALS Center

Print Friendly

Welcome to the USF ALS Clinic

The USF Amyotrophic Lateral Sclerosis (ALS) Clinic in Tampa offers multidisciplinary treatment, supportive care and information to help manage the effects of ALS on patients, their families and caregivers. The ALS Clinic staff includes neurologists, care coordinators, occupational & physical therapists, speech pathologists, dieticians, respiratory therapists, social workers, and a research coordinator. Pulmonologists, gastroenterologists and psychiatrists are also available for consultation. These devoted providers are all experienced in the care and treatment of ALS.

Patients, their families and caregivers seen at the ALS Clinic have the opportunity to meet with all members of the ALS care team. The ALS Clinic is held in the Department of Neurology on USF Campus at the Carol & Frank Morsani Center.

Tuan H. Vu, MD

Lara W. Katzin, MD
Tuan H. Vu, MD
Professor, Department of Neurology
Director, Neuromuscular Division, ALS Clinic & EMG Laboratory
Lara W. Katzin, MD
Assistant Professor, Department of Neurology
Co-Director, ALS Clinic

Helpful Links

Contact Us

ALS Walk Neurology Scheduling Line
(813) 396-9478

Natalie Tucker
ALS Clinic Coordinator
EMG/NCV Technician
813-974-9273 Phone
813-905-9820 Fax

Brittany Golden
ALS Clinic Co-Coordinator
Research Support Specialist
813-974-9413 Phone
813-974-7138 Fax

Mission Statement

We strive to instill hope and improve the daily lives of our patients, families and caregivers while maintaining dignity, offering support, and providing the highest level of care for these courageous individuals.

About Us

The USF ALS Clinic is directed by Tuan Vu, M.D. and co-directed by Lara Katzin, M.D., Dr. Clifton L. Gooch, Neurology Chairman, and Dr. Hera Stephens are also supporting physicians in clinic. The clinic is coordinated by Natalie Tucker and Brittany Golden. We collaborate with several clinical sites in the Tampa Bay area and with other universities around the country to conduct clinical trials for the study of ALS. Our focus is on:

  • Improved quality of life
  • Pharmacologic therapies
  • Palliative care

We closely partner with the ALS Association, Florida Chapter which supports our clinic activities and patients.

Your Support

The USF ALS Clinic has been funded by a generous donation from the Blume family who has played a pivotal part in generating momentum for the opening of our ALS Clinic in October of 2010. The ALS Clinic still needs ongoing financial support to fund the clinic staff and provide the highest quality of care and assistance we can offer our patients and their families. For information about how you can help support neuromuscular research, please visit the USF Foundation website.

For more information on making a donation to the USF ALS Center please contact:

Brittany Golden
813-974-9413
Email: bgolden1@health.usf.edu

Latest News

USF Morsani Center for Advanced HealthcareThe USF ALS clinic is now working diligently to become involved with various clinical trials researching treatments for ALS. We work closely with patients as possible trial candidates and strive to provide opportunities for interested patients to participate in research.

(View Map and Driving Directions)


Clinical Trials and Research

Name
Funding Source
Purpose
Contact
Status
A Study to Explore the Safety and Tolerability of Acthar in Patients with ALS
Questcor Pharmaceuticals, Inc.
This study is being conducted to determine whether Acthar is safe and tolerable for patients with Amyotrophic Lateral Sclerosis (ALS). Acthar is a subcutaneous injection.
Brittany Golden
(813) 974-9413
Enrolling
A Pilot Study of Granulocyte Colony Stimulation Factor Therapy in Patients with Amyotrophic Lateral Sclerosis (ALS)
Private Donation
This study is being conducted to determine the persistence of bone-marrow derived stem cells in the circulatory system after treatment with G-CSF (Filgrastim, Neupogen®) and the safety of high frequency administration of Filgrastim in patients with ALS. Filgrastim is a subcutaneous injection.
Terry McClain
(813) 396-9004
Enrolling
Effects of Expiratory Muscle Strength Training in Person's with Amyotrophic Lateral Sclerosis
 
This study is being conducted to determine whether expiratory muscle strength training slows the decline of respiratory function in ALS patients.
Brittany Golden
(813) 974-9413
Enrolling
EMPOWER – Phase 3 Trial of Dexpramipexole in ALS
Biogen Idec
This study is being conducted to determine whether dexpramipexole is safe and effective in the treatment of Amyotrophic Lateral Sclerosis (ALS). Dexpramipexole is an oral medication taken twice daily.
Brittany Golden
(813) 974-9413
Enrollment Closed
ENVISION - Open-Label Trial of Dexpramipexole in ALS
Biogen Idec
This study is being conducted to further determine whether dexpramipexole is safe and effective in the treatment of Amyotrophic Lateral Sclerosis (ALS). Dexpramipexole is an oral medication taken twice daily. This is an open-label extension from the EMPOWER trial.
Brittany Golden
(813) 974-9413
Enrollment Closed
Is There an ALS Personality?
Not Funded
This study is being conducted to determine if there is a specific personality of ALS patients. There is no treatment involved with this study and requires the patient and primary caregiver to fill out paper questionnaires.
Brittany Golden
(813) 974-9413
Enrollment Closed